Results 161 to 170 of about 6,150,654 (190)

TROP-2 overexpression in papillary renal cell carcinoma supports its potential as a therapeutic target for antibody-drug-conjugate therapy. [PDF]

open access: yesWorld J Urol
Kessler C   +12 more
europepmc   +1 more source

Comparative Transcriptomics Study of Curcumin and Conventional Therapies in Translocation, Clear Cell, and Papillary Renal Cell Carcinoma Subtypes. [PDF]

open access: yesInt J Mol Sci
Abah MO   +15 more
europepmc   +1 more source

Dephosphorylation-related signature predicts the prognosis of papillary renal cell carcinoma. [PDF]

open access: yesTransl Cancer Res
Feng J   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy